 Ding Xue
Concepts (348)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 42 | 2026 | 326 | 10.880 |
Why?
| | Caenorhabditis elegans Proteins | 38 | 2026 | 207 | 9.410 |
Why?
| | Apoptosis | 33 | 2022 | 2440 | 3.680 |
Why?
| | Caspases | 21 | 2017 | 233 | 3.450 |
Why?
| | Mitochondria | 12 | 2025 | 992 | 2.440 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 10 | 2019 | 239 | 1.960 |
Why?
| | Cathepsin B | 2 | 2026 | 17 | 1.570 |
Why?
| | Endodeoxyribonucleases | 7 | 2016 | 77 | 1.300 |
Why?
| | Phosphatidylserines | 5 | 2013 | 62 | 1.300 |
Why?
| | Mitochondrial Proteins | 7 | 2016 | 263 | 1.190 |
Why?
| | Embryonic Development | 4 | 2025 | 125 | 1.160 |
Why?
| | Phospholipid Transfer Proteins | 3 | 2019 | 7 | 1.120 |
Why?
| | Membrane Proteins | 9 | 2015 | 1164 | 1.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 4 | 2019 | 440 | 1.010 |
Why?
| | Repressor Proteins | 6 | 2016 | 429 | 0.950 |
Why?
| | Germ Cells | 5 | 2026 | 65 | 0.950 |
Why?
| | Mutagenesis | 2 | 2026 | 194 | 0.920 |
Why?
| | Carcinoma, Renal Cell | 4 | 2022 | 230 | 0.920 |
Why?
| | Animals | 54 | 2026 | 38030 | 0.880 |
Why?
| | DNA Fragmentation | 4 | 2016 | 40 | 0.860 |
Why?
| | Deoxyribonucleases | 4 | 2010 | 24 | 0.820 |
Why?
| | Kidney Neoplasms | 4 | 2022 | 413 | 0.800 |
Why?
| | Cell Division | 1 | 2025 | 756 | 0.770 |
Why?
| | Amino Acid Sequence | 17 | 2015 | 2129 | 0.770 |
Why?
| | Trans-Activators | 3 | 2019 | 396 | 0.750 |
Why?
| | Amino Acid Motifs | 4 | 2019 | 219 | 0.740 |
Why?
| | Intracellular Space | 2 | 2012 | 64 | 0.730 |
Why?
| | DNA, Helminth | 6 | 2010 | 26 | 0.720 |
Why?
| | Evolution, Molecular | 1 | 2026 | 492 | 0.720 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2023 | 192 | 0.710 |
Why?
| | Signal Transduction | 15 | 2026 | 5216 | 0.700 |
Why?
| | DNA, Mitochondrial | 3 | 2023 | 211 | 0.690 |
Why?
| | Embryo, Nonmammalian | 8 | 2025 | 171 | 0.690 |
Why?
| | Molecular Sequence Data | 16 | 2015 | 2883 | 0.660 |
Why?
| | Mutation | 16 | 2026 | 4075 | 0.640 |
Why?
| | Calcium-Binding Proteins | 3 | 2016 | 221 | 0.640 |
Why?
| | Animals, Genetically Modified | 8 | 2019 | 246 | 0.630 |
Why?
| | Sex Determination Processes | 2 | 2010 | 11 | 0.600 |
Why?
| | Apoptosis Regulatory Proteins | 5 | 2019 | 187 | 0.550 |
Why?
| | Carrier Proteins | 3 | 2021 | 728 | 0.540 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 372 | 0.540 |
Why?
| | Cadherins | 1 | 2019 | 200 | 0.540 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 81 | 0.530 |
Why?
| | Caspase Inhibitors | 4 | 2017 | 81 | 0.520 |
Why?
| | Calcium | 2 | 2012 | 1190 | 0.480 |
Why?
| | Fertilization | 1 | 2016 | 43 | 0.480 |
Why?
| | Cognition | 1 | 2024 | 1266 | 0.470 |
Why?
| | Intestines | 1 | 2019 | 354 | 0.460 |
Why?
| | RNA Interference | 7 | 2019 | 475 | 0.460 |
Why?
| | MicroRNAs | 2 | 2019 | 686 | 0.450 |
Why?
| | Nanoparticles | 4 | 2022 | 517 | 0.450 |
Why?
| | DNA | 4 | 2009 | 1435 | 0.440 |
Why?
| | Models, Molecular | 5 | 2021 | 1598 | 0.420 |
Why?
| | Molecular Biology | 1 | 2014 | 58 | 0.400 |
Why?
| | Optical Imaging | 4 | 2022 | 61 | 0.390 |
Why?
| | Caspase 3 | 1 | 2014 | 242 | 0.380 |
Why?
| | Microscopy, Immunoelectron | 1 | 2012 | 43 | 0.370 |
Why?
| | Protein Binding | 9 | 2021 | 2238 | 0.370 |
Why?
| | Phagocytosis | 4 | 2013 | 296 | 0.360 |
Why?
| | Germanium | 1 | 2012 | 2 | 0.360 |
Why?
| | Graphite | 1 | 2012 | 14 | 0.360 |
Why?
| | Autophagy | 3 | 2025 | 291 | 0.350 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2012 | 117 | 0.340 |
Why?
| | Fluorescent Dyes | 5 | 2021 | 333 | 0.340 |
Why?
| | Theranostic Nanomedicine | 3 | 2022 | 15 | 0.340 |
Why?
| | Proto-Oncogene Proteins | 3 | 2021 | 624 | 0.340 |
Why?
| | Hepatocytes | 1 | 2012 | 224 | 0.340 |
Why?
| | Adenosine Triphosphate | 2 | 2024 | 500 | 0.340 |
Why?
| | Lysosomes | 1 | 2011 | 131 | 0.330 |
Why?
| | Cell Membrane | 3 | 2013 | 707 | 0.330 |
Why?
| | Virus Replication | 2 | 2019 | 521 | 0.330 |
Why?
| | Intracellular Membranes | 2 | 2015 | 77 | 0.330 |
Why?
| | Carbon | 1 | 2012 | 176 | 0.330 |
Why?
| | Ribonuclease III | 1 | 2010 | 43 | 0.310 |
Why?
| | DNA Damage | 3 | 2026 | 437 | 0.300 |
Why?
| | Caspase 2 | 1 | 2009 | 12 | 0.300 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2015 | 387 | 0.290 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2008 | 15 | 0.280 |
Why?
| | Cysteine Endopeptidases | 3 | 2004 | 78 | 0.280 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2016 | 910 | 0.270 |
Why?
| | Receptors, Notch | 1 | 2008 | 90 | 0.260 |
Why?
| | Multienzyme Complexes | 2 | 2006 | 65 | 0.260 |
Why?
| | Cell Line, Tumor | 9 | 2022 | 3542 | 0.260 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 452 | 0.260 |
Why?
| | Protein Transport | 3 | 2021 | 442 | 0.260 |
Why?
| | Cloning, Molecular | 4 | 2015 | 538 | 0.260 |
Why?
| | Base Sequence | 5 | 2015 | 2170 | 0.260 |
Why?
| | Toluene | 1 | 2006 | 12 | 0.250 |
Why?
| | Benzene | 1 | 2006 | 18 | 0.250 |
Why?
| | Cobalt | 1 | 2007 | 50 | 0.250 |
Why?
| | Genome | 3 | 2014 | 305 | 0.250 |
Why?
| | Green Fluorescent Proteins | 3 | 2015 | 407 | 0.250 |
Why?
| | Helminth Proteins | 3 | 2001 | 24 | 0.240 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2021 | 1443 | 0.240 |
Why?
| | RNA-Binding Proteins | 1 | 2010 | 447 | 0.240 |
Why?
| | Cell Death | 3 | 2015 | 382 | 0.240 |
Why?
| | bcl-X Protein | 2 | 2019 | 45 | 0.240 |
Why?
| | Chlorobenzenes | 1 | 2006 | 18 | 0.240 |
Why?
| | Biphenyl Compounds | 1 | 2006 | 67 | 0.240 |
Why?
| | Hepatitis B virus | 2 | 2019 | 33 | 0.240 |
Why?
| | SELEX Aptamer Technique | 1 | 2006 | 16 | 0.240 |
Why?
| | Receptor, Insulin | 1 | 2026 | 93 | 0.230 |
Why?
| | Naphthalenes | 1 | 2006 | 54 | 0.230 |
Why?
| | Population Density | 1 | 2026 | 89 | 0.230 |
Why?
| | Viral Regulatory and Accessory Proteins | 3 | 2019 | 27 | 0.230 |
Why?
| | Structure-Activity Relationship | 3 | 2021 | 563 | 0.220 |
Why?
| | Blastomeres | 1 | 2025 | 11 | 0.220 |
Why?
| | Cytosol | 3 | 2012 | 213 | 0.220 |
Why?
| | Aptamers, Nucleotide | 1 | 2006 | 87 | 0.220 |
Why?
| | Enzyme Activation | 4 | 2015 | 762 | 0.220 |
Why?
| | Centrosome | 1 | 2025 | 71 | 0.210 |
Why?
| | Cell Cycle Proteins | 1 | 2008 | 630 | 0.210 |
Why?
| | Sexual Behavior, Animal | 1 | 2024 | 58 | 0.210 |
Why?
| | Embryo Loss | 1 | 2023 | 4 | 0.200 |
Why?
| | Permeability | 2 | 2015 | 169 | 0.200 |
Why?
| | Mitosis | 1 | 2025 | 193 | 0.200 |
Why?
| | Homeodomain Proteins | 1 | 2007 | 523 | 0.200 |
Why?
| | Recombinant Fusion Proteins | 4 | 2010 | 666 | 0.200 |
Why?
| | Forkhead Transcription Factors | 1 | 2024 | 207 | 0.200 |
Why?
| | Nuclear Proteins | 1 | 2008 | 740 | 0.190 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 156 | 0.190 |
Why?
| | Models, Biological | 4 | 2019 | 1764 | 0.190 |
Why?
| | Reproduction | 1 | 2024 | 208 | 0.190 |
Why?
| | TNF Receptor-Associated Factor 1 | 1 | 2022 | 8 | 0.180 |
Why?
| | Phototherapy | 2 | 2022 | 49 | 0.180 |
Why?
| | Sequence Alignment | 3 | 2009 | 362 | 0.180 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 611 | 0.180 |
Why?
| | Methyltransferases | 1 | 2022 | 75 | 0.170 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2597 | 0.170 |
Why?
| | Callithrix | 1 | 2021 | 10 | 0.170 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2019 | 145 | 0.170 |
Why?
| | Nuclear Receptor Subfamily 2, Group C, Member 2 | 1 | 2021 | 1 | 0.170 |
Why?
| | Pro-Opiomelanocortin | 1 | 2021 | 20 | 0.170 |
Why?
| | In Situ Nick-End Labeling | 3 | 2010 | 119 | 0.170 |
Why?
| | Behavior, Animal | 1 | 2024 | 519 | 0.170 |
Why?
| | Binding Sites | 3 | 2021 | 1310 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 142 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2003 | 425 | 0.160 |
Why?
| | Polymers | 2 | 2022 | 485 | 0.160 |
Why?
| | Nanomedicine | 1 | 2021 | 47 | 0.160 |
Why?
| | Phagocytes | 2 | 2012 | 80 | 0.160 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 155 | 0.160 |
Why?
| | Adenosine | 1 | 2022 | 255 | 0.160 |
Why?
| | Annexin A5 | 2 | 2012 | 23 | 0.160 |
Why?
| | Cysteine Proteases | 1 | 2019 | 8 | 0.150 |
Why?
| | Male | 13 | 2025 | 72842 | 0.150 |
Why?
| | Bystander Effect | 1 | 2019 | 19 | 0.150 |
Why?
| | Indocyanine Green | 1 | 2019 | 42 | 0.150 |
Why?
| | Transcription Factors | 1 | 2007 | 1734 | 0.150 |
Why?
| | Lasers | 1 | 2020 | 126 | 0.150 |
Why?
| | Cerebral Angiography | 1 | 2019 | 119 | 0.150 |
Why?
| | Cell Survival | 4 | 2017 | 1100 | 0.150 |
Why?
| | Nomograms | 1 | 2019 | 59 | 0.150 |
Why?
| | DNA Primers | 2 | 2015 | 505 | 0.150 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2019 | 258 | 0.140 |
Why?
| | Cell Tracking | 1 | 2018 | 18 | 0.140 |
Why?
| | Neoplasm Grading | 1 | 2019 | 310 | 0.140 |
Why?
| | Ubiquitin | 2 | 2011 | 83 | 0.140 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2018 | 18 | 0.140 |
Why?
| | Microscopy, Fluorescence | 1 | 2019 | 408 | 0.130 |
Why?
| | Endocytosis | 1 | 2019 | 168 | 0.130 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1767 | 0.130 |
Why?
| | Receptors, Steroid | 1 | 2018 | 42 | 0.130 |
Why?
| | Seminoma | 1 | 2018 | 20 | 0.130 |
Why?
| | Hep G2 Cells | 2 | 2019 | 73 | 0.130 |
Why?
| | Testicular Neoplasms | 1 | 2018 | 111 | 0.120 |
Why?
| | Phenotype | 3 | 2019 | 3155 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2023 | 599 | 0.120 |
Why?
| | Female | 8 | 2025 | 78844 | 0.120 |
Why?
| | Mitochondrial Membranes | 1 | 2016 | 40 | 0.120 |
Why?
| | Humans | 21 | 2023 | 145474 | 0.120 |
Why?
| | Surface Properties | 2 | 2020 | 386 | 0.120 |
Why?
| | Oxidation-Reduction | 3 | 2016 | 1067 | 0.120 |
Why?
| | Protein Conformation | 1 | 2019 | 938 | 0.120 |
Why?
| | Particle Size | 2 | 2020 | 381 | 0.110 |
Why?
| | Dynamins | 1 | 2015 | 36 | 0.110 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2007 | 157 | 0.110 |
Why?
| | Spermatozoa | 1 | 2016 | 106 | 0.110 |
Why?
| | Mice, Inbred ICR | 3 | 2020 | 113 | 0.110 |
Why?
| | Molecular Structure | 2 | 2006 | 486 | 0.110 |
Why?
| | Cell Movement | 1 | 2019 | 959 | 0.110 |
Why?
| | Time-Lapse Imaging | 1 | 2015 | 21 | 0.110 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1261 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2015 | 148 | 0.110 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 41 | 0.110 |
Why?
| | Pharynx | 2 | 2008 | 59 | 0.110 |
Why?
| | Cell Nucleus | 3 | 2003 | 588 | 0.110 |
Why?
| | Fluorescence | 1 | 2015 | 159 | 0.100 |
Why?
| | Computational Biology | 1 | 2019 | 669 | 0.100 |
Why?
| | Mammals | 1 | 2015 | 286 | 0.100 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 345 | 0.100 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 317 | 0.100 |
Why?
| | Transcriptome | 1 | 2019 | 1038 | 0.100 |
Why?
| | Genes, Suppressor | 1 | 2012 | 4 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1149 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 848 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1321 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 382 | 0.090 |
Why?
| | Blotting, Western | 1 | 2015 | 1179 | 0.090 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 139 | 0.090 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 384 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 777 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1041 | 0.090 |
Why?
| | Necrosis | 1 | 2012 | 244 | 0.090 |
Why?
| | Electrodes | 1 | 2012 | 111 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 855 | 0.090 |
Why?
| | Mice | 6 | 2021 | 18329 | 0.080 |
Why?
| | Lipids | 2 | 2015 | 707 | 0.080 |
Why?
| | Down-Regulation | 3 | 2021 | 618 | 0.080 |
Why?
| | Time Factors | 3 | 2014 | 7123 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2012 | 142 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 7202 | 0.080 |
Why?
| | RNA, Helminth | 1 | 2010 | 18 | 0.080 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 207 | 0.080 |
Why?
| | 3' Untranslated Regions | 1 | 2010 | 149 | 0.080 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 51 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2018 | 2507 | 0.080 |
Why?
| | Alleles | 1 | 2013 | 894 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 456 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 637 | 0.070 |
Why?
| | Infrared Rays | 2 | 2020 | 24 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2016 | 1356 | 0.070 |
Why?
| | Genes, bcl-2 | 1 | 2009 | 22 | 0.070 |
Why?
| | Catalytic Domain | 1 | 2010 | 234 | 0.070 |
Why?
| | Neurons | 2 | 2008 | 1649 | 0.070 |
Why?
| | Ubiquitin-Protein Ligase Complexes | 1 | 2008 | 8 | 0.070 |
Why?
| | Cullin Proteins | 1 | 2008 | 14 | 0.070 |
Why?
| | Recombinant Proteins | 2 | 2003 | 1368 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2009 | 414 | 0.070 |
Why?
| | Dimerization | 1 | 2008 | 189 | 0.070 |
Why?
| | POU Domain Factors | 1 | 2007 | 6 | 0.070 |
Why?
| | Muscle Cells | 1 | 2008 | 41 | 0.070 |
Why?
| | Genes, Helminth | 1 | 2007 | 30 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2008 | 244 | 0.070 |
Why?
| | X Chromosome | 1 | 2007 | 65 | 0.070 |
Why?
| | Protein Subunits | 1 | 2008 | 229 | 0.070 |
Why?
| | Benzene Derivatives | 1 | 2006 | 7 | 0.060 |
Why?
| | Brain | 1 | 2019 | 2947 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2020 | 2382 | 0.060 |
Why?
| | Electrochemistry | 1 | 2007 | 70 | 0.060 |
Why?
| | Cyclohexanes | 1 | 2006 | 22 | 0.060 |
Why?
| | Nucleic Acid Hybridization | 1 | 2007 | 187 | 0.060 |
Why?
| | Peptides | 1 | 2012 | 998 | 0.060 |
Why?
| | Staining and Labeling | 1 | 2007 | 153 | 0.060 |
Why?
| | Benzoquinones | 1 | 2006 | 46 | 0.060 |
Why?
| | Mutation, Missense | 1 | 2008 | 335 | 0.060 |
Why?
| | Larva | 2 | 2014 | 240 | 0.060 |
Why?
| | Oils | 1 | 2006 | 22 | 0.060 |
Why?
| | Crystallography, X-Ray | 2 | 2019 | 486 | 0.060 |
Why?
| | Kinetics | 1 | 2009 | 1567 | 0.060 |
Why?
| | Carcinogens | 1 | 2006 | 123 | 0.060 |
Why?
| | Growth and Development | 1 | 2006 | 9 | 0.060 |
Why?
| | Cell Count | 1 | 2006 | 319 | 0.060 |
Why?
| | Catalysis | 1 | 2007 | 305 | 0.060 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 143 | 0.060 |
Why?
| | Biological Transport | 1 | 2007 | 424 | 0.060 |
Why?
| | Protein Structure, Secondary | 1 | 2006 | 371 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1048 | 0.050 |
Why?
| | Membrane Potentials | 1 | 2004 | 278 | 0.050 |
Why?
| | rac GTP-Binding Proteins | 1 | 2003 | 35 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 675 | 0.050 |
Why?
| | Peptide Hydrolases | 1 | 2004 | 105 | 0.050 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2003 | 64 | 0.050 |
Why?
| | Apoptosis Inducing Factor | 1 | 2002 | 3 | 0.050 |
Why?
| | Flavoproteins | 1 | 2002 | 8 | 0.050 |
Why?
| | Swimming | 1 | 2023 | 54 | 0.050 |
Why?
| | Hydrolysis | 1 | 2003 | 197 | 0.050 |
Why?
| | Acoustics | 1 | 2023 | 48 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8333 | 0.050 |
Why?
| | Pyridines | 1 | 2007 | 609 | 0.050 |
Why?
| | Sex Factors | 1 | 2008 | 2105 | 0.050 |
Why?
| | Sex Characteristics | 1 | 2007 | 782 | 0.040 |
Why?
| | Genetic Complementation Test | 1 | 2001 | 72 | 0.040 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 468 | 0.040 |
Why?
| | Disease Progression | 2 | 2021 | 2864 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1997 | 0.040 |
Why?
| | Pituitary ACTH Hypersecretion | 1 | 2021 | 12 | 0.040 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 12 | 0.040 |
Why?
| | Quantum Dots | 1 | 2021 | 37 | 0.040 |
Why?
| | Mixed Function Oxygenases | 1 | 2021 | 43 | 0.040 |
Why?
| | Molecular Conformation | 1 | 2021 | 141 | 0.040 |
Why?
| | Alcohol Oxidoreductases | 1 | 2021 | 61 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 286 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2022 | 238 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 147 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1480 | 0.040 |
Why?
| | Microscopy, Interference | 1 | 2000 | 8 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 506 | 0.040 |
Why?
| | Semiconductors | 1 | 2020 | 27 | 0.040 |
Why?
| | Aged | 4 | 2023 | 26153 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2021 | 337 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4316 | 0.040 |
Why?
| | Drug Discovery | 1 | 2021 | 153 | 0.040 |
Why?
| | Intracranial Thrombosis | 1 | 2019 | 19 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2000 | 302 | 0.040 |
Why?
| | HeLa Cells | 1 | 2001 | 632 | 0.040 |
Why?
| | Disorders of Sex Development | 1 | 2000 | 40 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4560 | 0.040 |
Why?
| | Neoplasms | 1 | 2015 | 2906 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 307 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 192 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2019 | 319 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2018 | 194 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 167 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 177 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 934 | 0.030 |
Why?
| | Caspases, Initiator | 1 | 2017 | 16 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2017 | 90 | 0.030 |
Why?
| | Naproxen | 1 | 2017 | 21 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 679 | 0.030 |
Why?
| | Ketorolac | 1 | 2017 | 33 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2022 | 881 | 0.030 |
Why?
| | Ibuprofen | 1 | 2017 | 87 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2016 | 73 | 0.030 |
Why?
| | Protein Structure, Quaternary | 1 | 2016 | 116 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 506 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2017 | 387 | 0.030 |
Why?
| | Polyethylene Glycols | 1 | 2021 | 649 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 219 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1476 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 111 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2003 | 4148 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 741 | 0.030 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2014 | 7 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2016 | 204 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 176 | 0.030 |
Why?
| | HCT116 Cells | 1 | 2015 | 76 | 0.030 |
Why?
| | Genetic Pleiotropy | 1 | 2014 | 30 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 847 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2090 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2021 | 1454 | 0.030 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 82 | 0.030 |
Why?
| | Fluorouracil | 1 | 2015 | 231 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1471 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2014 | 191 | 0.020 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 6 | 0.020 |
Why?
| | Middle Aged | 3 | 2021 | 36215 | 0.020 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 8 | 0.020 |
Why?
| | Cell Lineage | 1 | 2014 | 377 | 0.020 |
Why?
| | Ligands | 1 | 2015 | 665 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 151 | 0.020 |
Why?
| | Adult | 3 | 2021 | 40777 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2823 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5423 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5983 | 0.020 |
Why?
| | Rats | 1 | 2012 | 5584 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 17291 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 14218 | 0.010 |
Why?
|
|
Xue's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|